What is the effect of Sotalol (beta blocker) on blood pressure (BP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: March 13, 2025 • View editorial policy

From the FDA Drug Label

In hypertensive patients, sotalol produces significant reductions in both systolic and diastolic blood pressures. The effect of Sotalol on blood pressure (BP) is a reduction in both systolic and diastolic blood pressures in hypertensive patients 1.

  • Key points: + Sotalol reduces blood pressure in hypertensive patients + The reduction is seen in both systolic and diastolic blood pressures + Caution should be exercised in patients with marginal cardiac compensation as deterioration in cardiac performance may occur.

From the Research

Sotalol is effective in reducing blood pressure in patients with mild-to-moderate essential hypertension, with its effect comparable to other beta-blockers, as evidenced by studies such as 2 and 3. The primary mechanism through which sotalol lowers blood pressure is by blocking beta-1 receptors in the heart, reducing heart rate and cardiac output, and inhibiting the release of renin from the kidneys, which helps regulate blood pressure through the renin-angiotensin-aldosterone system. Additionally, sotalol has Class III antiarrhythmic properties, meaning it prolongs cardiac action potential duration and effective refractory period, which is why it's often used to treat arrhythmias rather than hypertension alone.

Some key points to consider when prescribing sotalol for blood pressure management include:

  • Typical dosing ranges from 80-160 mg twice daily, though this varies based on individual patient factors, as noted in 2 and 4.
  • Patients should be aware that sotalol can cause bradycardia (slow heart rate), fatigue, and may worsen asthma or COPD symptoms due to its beta-2 blocking effects, as reported in 3 and 4.
  • It should be taken consistently at the same times each day, and patients should never stop taking it abruptly as this can cause rebound hypertension or worsen cardiac conditions, a precaution highlighted in 2 and 5.

The most recent and highest quality study, 4, demonstrates the efficacy of sotalol in suppressing chronic ventricular arrhythmias, further supporting its use in patients with cardiovascular conditions. However, it's essential to weigh the benefits against potential risks, such as proarrhythmia, and closely monitor patients, especially when initiating or adjusting therapy, as cautioned in 4.

In terms of specific patient populations, sotalol may be particularly useful for those with arrhythmias, as its Class III antiarrhythmic properties can help maintain sinus rhythm and prevent recurrence of arrhythmias, as discussed in 6 and 3. However, its use in patients with severe hypertension or those with certain comorbidities, such as asthma or COPD, requires careful consideration and monitoring, as noted in 2 and 5.

Overall, sotalol is a valuable option for managing blood pressure in patients with mild-to-moderate essential hypertension, particularly those with arrhythmias, but its use requires careful patient selection, dosing, and monitoring to minimize potential risks and maximize benefits, as emphasized in 2, 3, and 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.